Clinical Trials Browser

Phase 2 × CBLB502 × Gastrointestinal × Clear all

NCT02715882 2017-02-09

Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer

Phase 2 Unknown

Gastrointestinal

Colorectal Neoplasms